Get the Stockscreener App
2.46
5.02%
-0.13
After Hours:
2.54
0.08
+3.25%
Connect Biopharma Holdings Ltd stock is traded at $2.46, with a volume of 51,014.
It is down -5.02% in the last 24 hours and up +6.96% over the past month.
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
See More
Previous Close:
$2.59
Open:
$2.55
24h Volume:
51,014
Relative Volume:
0.46
Market Cap:
$137.52M
Revenue:
-
Net Income/Loss:
$-21.38M
P/E Ratio:
-6.3077
EPS:
-0.39
Net Cash Flow:
$-25.19M
1W Performance:
-2.38%
1M Performance:
+6.96%
6M Performance:
+40.57%
1Y Performance:
+179.55%
1-Day Range:
$2.455
$2.59
1-Week Range:
$2.37
$2.67
52-Week Range:
$0.51
$3.28
Connect Biopharma Holdings Ltd Stock (CNTB) Company Profile
Name
Connect Biopharma Holdings Ltd
Sector
Industry
Phone
858-727-1040
Address
3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO
Compare CNTB vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNTB
Connect Biopharma Holdings Ltd
|
2.46 | 144.79M | 0 | -21.38M | -25.19M | -0.39 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Connect Biopharma Holdings Ltd Stock (CNTB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-01-25 | Initiated | Lake Street | Buy |
| Oct-31-25 | Initiated | BTIG Research | Buy |
| Jun-12-25 | Initiated | H.C. Wainwright | Buy |
| Mar-04-24 | Initiated | H.C. Wainwright | Buy |
| Apr-13-21 | Initiated | Jefferies | Buy |
| Apr-13-21 | Initiated | Piper Sandler | Overweight |
| Apr-13-21 | Initiated | SVB Leerink | Outperform |
View All
Connect Biopharma Holdings Ltd Stock (CNTB) Latest News
Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference - The Manila Times
CNTB Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
GNLX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
SELX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CNTB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
UCL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
CNTB Technical Analysis & Stock Price Forecast - Intellectia AI
Connect Biopharma Touts Rademikibart as Fast-Acting Option for Acute Asthma, COPD Flare-Ups at Conference - MarketBeat
BML Capital Management LLC Sells 554,058 Shares of Connect Biopharma Holdings Limited Sponsored ADR $CNTB - MarketBeat
KraneShares CSI China Internet ETF $KWEB Shares Purchased by Aurora Investment Managers LLC. - Defense World
Invesco QQQ $QQQ Stock Position Lessened by Concentrum Wealth Management - Defense World
JD.com, Inc. $JD Shares Acquired by Aurora Investment Managers LLC. - Defense World
Connect Biopharma to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - The Manila Times
Watch Connect Biopharma's Oppenheimer health conference talk online - Stock Titan
Wubin Pan and BioFortune Inc. disclose 10.8% stake in Connect Biopharma (CNTB) - Stock Titan
Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight - Financial Times
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
CNTB PE Ratio & Valuation, Is CNTB Overvalued - Intellectia AI
What is HC Wainwright's Forecast for CNTB FY2028 Earnings? - MarketBeat
Connect Biopharma and Bimergen Energy Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Reno Gazette Journal
Equities Analysts Offer Predictions for CNTB FY2030 Earnings - MarketBeat
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI), Ardelyx (ARDX) and AxoGen (AXGN) - The Globe and Mail
Analysts’ Top Healthcare Picks: Context Therapeutics (CNTX), Connect Biopharma Holdings (CNTB) - The Globe and Mail
3 Promising Penny Stocks With Market Caps Up To $400M - Yahoo Finance
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
OPAL Fuels Inc. (NASDAQ:OPAL) Given Average Recommendation of “Reduce” by Analysts - Defense World
NVR, Inc. (NYSE:NVR) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Contrasting Joint Stock Company Kaspi.kz (NASDAQ:KSPI) & PagSeguro Digital (NYSE:PAGS) - Defense World
Connect Biopharma (NASDAQ:CNTB) Shares Down 2.7%What's Next? - MarketBeat
Connect Biopharma (NASDAQ:CNTB) Shares Down 2.7% – What’s Next? - Defense World
Plus Therapeutics Spurs After-Hours Biotech Rally; Connect Biopharma And Elutia Also Advance - Nasdaq
Connect Biopharma Highlights New Mechanism of Action Data for Rademikibart and Outlines Priorities for 2026 - The Manila Times
Connect Biopharma Reports Significant Loss Amid Development Efforts - MSN
Join Connect Biopharma's Exclusive Live Investor Webinar and Q&A Session on November 3 - news-journalonline.com
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Aptevo Therapeutics (APVO) Stock Price, Quote, News & History - Benzinga
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Connect Biopharma Announces Board Resignation - TradingView — Track All Markets
Discovering Connect Biopharma Holdings And 2 Other Promising Penny Stocks - simplywall.st
Connect Biopharma (NASDAQ:CNTB) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
Connect Biopharma Hldgs (CNTB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Connect Biopharma Holdings Limited's (NASDAQ:CNTB) largest shareholders are private equity firms with 39% ownership, individual investors own 22% - Yahoo Finance
Analyzing Connect Biopharma (NASDAQ:CNTB) and Axsome Therapeutics (NASDAQ:AXSM) - Defense World
Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Receives $8.50 Average Price Target from Analysts - Defense World
Connect Biopharma Holdings Ltd Stock (CNTB) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):